11:40 AM
 | 
Mar 12, 2019
 |  BC Extra  |  Financial News

InventisBio raises $70M series C to advance early stage pipeline

Editor's Note: This article was updated on Mar 12, 2019 at 4:11 PM PDT

InventisBio raised $70 million in a series C round led by Advantech Capital and CMBI, the Chinese biotech announced late Monday. Pudong Innotek and existing investors Lilly Asia Ventures and OrbiMed Asia also participated in the round, which InventisBio Inc. (Shanghai, China) said...

Read the full 192 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >